(Q35172333)

6 August 2017

1 reference

title

Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment (English)

1 reference

mild cognitive impairment

6 August 2017

main subject

1 reference

inferred from title

cognitive dysfunction

1 reference

1

Charles DeCarli

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

15-21

1 reference

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Correlates of Self-Reported Everyday Memory Problems

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

The prevalence of cognitive impairment in an elderly Canadian population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Current concepts in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Classification criteria for mild cognitive impairment: a population-based validation study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Mild cognitive impairment: conceptual basis and current nosological status.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Aging-Associated Cognitive Decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Evidence that age-associated memory impairment is not a normal variant of aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Are memory complaints predictive for dementia? A review of clinical and population-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Aging, mild cognitive impairment, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

ICD-10 mild cognitive disorder: epidemiological evidence on its validity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Prevalence and outcomes of vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Aging, memory, and mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Validation of clinical diagnostic criteria for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

1 reference

7 January 2021

Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Mild cognitive impairment in the population and physical health: data on 1,435 individuals aged 75 to 95.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Mortality in nondemented subjects with cognitive impairment: the influence of health-related factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Memory complaints and impairment in normal, depressed, and demented elderly persons identified in a community survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Probability of stroke: a risk profile from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Brain structure and cognition in a community sample of elderly Latinos

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Spectrum of disease in vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment. Value of the Mini-Mental State Examination.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Progression of impairment in patients with vascular cognitive impairment without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Natural history of mild cognitive impairment in older persons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Independent predictors of cognitive decline in healthy elderly persons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Predictive value of APOE genotyping in incipient Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Functional deficits in patients with mild cognitive impairment: prediction of AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

The impact of mild cognitive impairment on functional abilities in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Antihypertensive treatment and the prevention of dementia: further insights from the Syst-Eur trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

Trends in hypertension prevalence, treatment, and control: in a well-defined older population.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900262-X

7 January 2021

10.1016/S1474-4422(03)00262-X

Identifiers

DOI

1 reference

6 August 2017

1 reference